“The European Union is in no hurry to bring Sputnik V as a full-fledged commercial product to its market, fearing its high consumer properties, thanks to which it may slightly push back the products that the European bureaucracy is promoting at home,” RIA Novosti quoted him as saying.
The Russian vaccine against coronavirus "Sputnik V" has been undergoing a gradual examination procedure at the European Medicines Agency EMA since the beginning of March.
Earlier, Gunzburg spoke about the effectiveness of the Sputnik Light coronavirus vaccine.